Company intelligence / Profile preview

GABA Schweiz

Therwil, Basel-Landschaft, Switzerland

Ownership: Private
Development stage: Other

Overview

GABA is a leading Swiss oral care company specializing in the development and commercialization of scientifically-backed dental hygiene products. Originally established as the Goldene Apotheke Basel, the company is renowned for introducing amine fluoride technology, which is a cornerstone of its flagship brand, Elmex. Its portfolio also includes Meridol, focused on gum health, and Aronal, designed for morning oral protection. Since being acquired by Colgate-Palmolive in 2004, GABA has continued to serve as a center of excellence for oral health, maintaining strong ties with dental professionals and pharmacies across Europe.

Therapeutic areas: Infectious DiseasesOtherGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on GABA Schweiz.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GABA Schweiz.

Explore the full profile